Mutations in the proto-oncogene BRAF and RAS family genes (KRAS and NRAS) are quite frequent in melanoma, CRC, anaplastic thyroid cancer (ATC) and LAC, whilst alterations affecting genes encoding MEK and ERK have rarely been identified (131, 132). This evidence concerns the gene KRAS and colorectal carcinoma.